Browsing by Author TAN SHAO WENG DANIEL

Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)
25-Mar-2020A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinomaKong, Li Ren ; Salleh, Nur Afiqah Binte Mohamed ; Ong, Richard Weijie; Tan, Tuan Zea ; Syn, Nicholas L; Goh, Robby Miguel; Fhu, Chee Wei ; Tan, Daniel SW ; Iyer, N Gopalakrishna ; Kannan, Srinivasaraghavan; Verma, Chandra S ; Lim, Yaw Chyn ; Soo, Ross ; Ho, Jingshan ; Huang, Yiqing; Lim, Joline SJ ; Yan, Benedict Junrong; Nga, Min En ; Lim, Seng Gee ; Koeffler, H Phillip ; Lee, Soo Chin ; Kappei, Dennis ; Hung, Huynh The ; Goh, Boon Cher 
2017A systematic review and meta-analysis of individual patient data on the impact of the BIM deletion polymorphism on treatment outcomes in epidermal growth factor receptor mutant lung cancerSoh, S.X; Siddiqui, F.J ; Allen, J.C ; Kim, G.W; Lee, J.C; Yatabe, Y; Soda, M; Mano, H; Soo, R.A ; Chin, T.-M ; Ebi, H; Yano, S; Matsuo, K; Niu, X; Lu, S; Isobe, K; Lee, J.-H; Yang, J.C; Zhao, M; Zhou, C; Lee, J.-K; Lee, S.-H; Lee, J.Y; Ahn, M.-J; Tan, T.J; Tan, D.S ; Tan, E.-H; Ong, S.T ; Lim, W.-T 
2017A three gene immunohistochemical panel serves as an adjunct to clinical staging of patients with head and neck cancerOng C.-A.J. ; Shannon N.B.; Mueller S.; Lek S.M.; Qiu X.; Chong F.T.; Li K.; Koh K.K.N.; Tay G.C.A. ; Skanthakumar T.; Hwang J.S.G. ; Lim T.K.H. ; Ang M.K. ; Tan D.S.W. ; Tan N.-C. ; Tan H.K. ; Soo K.C. ; Iyer N.G. 
2018GNA13 expression promotes drug resistance and tumor-initiating phenotypes in squamous cell cancersRasheed, S.A.K ; Leong, H.S; Lakshmanan, M; Raju, A; Dadlani, D ; Chong, F.-T; Shannon, N.B; Rajarethinam, R; Skanthakumar, T; Tan, E.Y; Hwang, J.S.G ; Lim, K.H ; Tan, D.S.-W ; Ceppi, P; Wang, M ; Tergaonkar, V ; Casey, P.J ; Iyer, N.G 
2017Hydration effects on the efficacy of the Epidermal growth factor receptor kinase inhibitor afatinibKannan, S; Pradhan, M.R; Tiwari, G; Tan, W.-C; Chowbay, B ; Tan, E.H ; Tan, D.S.-W; Verma, C 
2015Impact of smoking and brain metastasis on outcomes of advanced EGFR mutation lung adenocarcinoma patients treated with first line epidermal growth factor receptor tyrosine kinase inhibitorsJain A.; Lim C. ; Gan E.M.; Ng D.Z.; Ng Q.S.; Ang M.K. ; Takano A. ; Chan K.S. ; Tan W.M.; Kanesvaran R. ; Toh C.K. ; Loo C.M. ; Hsu A.A.L. ; Devanand A. ; Lim C.H. ; Koong H.N. ; Koh T. ; Fong K.W. ; Yap S.P.; Kim S.W.; Chowbay B. ; Oon L. ; Lim K.H. ; Lim W.T. ; Tan E.H. ; Tan D.S.W.